Stereotactic body radiotherapy for central lung tumors, yes we can!
نویسندگان
چکیده
منابع مشابه
Stereotactic body radiotherapy: do central lung tumors still represent a 'no-fly zone'?.
criteria used for stage III tumors. Including patients with multiple ipsilateral mediastinal nodes, or those with any contralateral metastases, will inevitably increase doses to critical normal organs. Were high doses to the esophagus a reason to exclude patients, or to use a fraction size of 5 Gy, or even to accept lower tumor doses, as has been reported recently [8]? Further progress in this ...
متن کاملStereotactic ablative body radiotherapy for lung cancer.
Lung stereotactic ablative radiotherapy (SABR) is a method of delivering high 'ablative' doses of radiotherapy to tumours in the lung. It was developed at the Karolinska Institute in the early 1990s using the methods established in cranial radiosurgery with multiple beams prescribed to an isodose and using a custom designed stereotactic body frame for immobilisation. Since then, aligned with th...
متن کاملStereotactic Body Radiotherapy for the Treatment of Renal Tumors.
The purpose of this study was to evaluate the response of actively growing renal masses to stereotactic body radiation therapy (SBRT). We retrospectively reviewed our institutional review board-approved kidney database and identified 4 patients who underwent SBRT, 15 Gy dose, for their rapidly growing renal masses. Three patients had a decreased tumor size after radiation treatment by 20.8%, 38...
متن کاملStereotactic ablative radiotherapy for ultra-central lung tumors: prioritize target coverage or organs at risk?
BACKGROUND Lung stereotactic ablative radiotherapy (SABR) is associated with low morbidity, however there is an increased risk of treatment-related toxicity in tumors directly abutting or invading the proximal bronchial tree, termed 'ultra-central' tumors. As there is no consensus regarding the optimal radiotherapy treatment regimen for these tumors, we performed a modeling study to evaluate th...
متن کاملStereotactic body radiotherapy (SBRT) for high-risk central pulmonary metastases
BACKGROUND AND PURPOSE Radiotherapy of central lung tumors carries a higher risk of treatment-related toxicity and local failure. In the era of aggressive oligometastic management the exploration of the proper dose-fractionation for metastatic central lung tumors is essential. MATERIALS AND METHODS Patients diagnosed with high-risk metastatic lesions of the central pulmonary tree comprised th...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Radiation Oncology
سال: 2018
ISSN: 1748-717X
DOI: 10.1186/s13014-018-1017-y